Collegium Pharmaceutical Inc
NASDAQ:COLL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Collegium Pharmaceutical Inc
NASDAQ:COLL
|
US |
|
T
|
TXT e solutions SpA
F:TXE
|
IT |
|
T
|
TXT e solutions SpA
XMUN:TXE
|
IT |
|
E
|
Earth Tech Environment PCL
SET:ETC
|
TH |
Intrinsic Value
Is COLL undervalued or overvalued?
See the intrinsic value estimate for Collegium Pharmaceutical Inc and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
COLL looks undervalued.
But is it cheap by its own standards?
See how today’s valuation compares with COLL’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What Collegium Pharmaceutical Does
Collegium Pharmaceutical makes prescription medicines for pain management and related conditions. Its main product portfolio centers on branded therapies that doctors prescribe to patients who need longer-lasting pain control, especially in settings where other treatments have not worked well or are not appropriate. The company focuses on a narrow set of medicines rather than a broad drug catalog.
- Headquarters
- United States of America US
- Employees
- 423
- IPO date
- May 7, 2015
Revenue & Expenses Breakdown
Collegium Pharmaceutical Inc
Earnings Waterfall
Collegium Pharmaceutical Inc
The intrinsic value for Collegium Pharmaceutical Inc (COLL) under the Base Case is hidden USD.
Compared with the current market price of 23.18 USD, the stock appears hidden.